The story begins in 899 when Alfred Einhorn' reported the synthesis of procaine, for this stimulated a concentrated and prolonged search for the ideal topical anaesthetic. Particularly interested in the esters of benzoic and p-aminobenzoic acids, with procaine as the basic prototype molecule, research chemists were quick to note that alteration in any part of the three main constituents-acid, ester, and tertiary amino groups-altered anaesthetic potency and toxicity and that a more potent anaesthetic could be produced only at the cost of increased toxicity.
Topical anaesthetics are prescribed by the dermatologist, the proctologist, the gynaecologist, and the obstetrician for the relief of pruritus. Until recently, however, the majority of those in common use had certain drawbacks, particularly the production of sensitization and of contact dermatitis. These risks are frequently referred to in the literature. ' 
